REPLASHAY

Transkaryotic Therapies, Inc.

Application Filed: 2002-07-11

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	78143109
Mark Drawing Code	1000: Typeset: Word(s)/letter(s)/number(s)
Attorney Name	Mary S. Consalvi
Law Office Assigned	M70
Employee Name	LAWRENCE, SUSAN KASTRI

Timeline

2002-07-11	Application Filed
2003-08-05	Published for Opposition
2004-04-29	Abandon
2004-04-29	Status: Dead/Abandoned
2004-07-02	Location: FILE REPOSITORY (FRANCONIA)
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Transkaryotic Therapies, Inc.
Address	195 Albany Street Cambridge DE 02139
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Mary S. Consalvi
Mary S. Consalvi
195 Albany Street
Cambridge MA 02139

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	44
U.S. Codes:	100,101

Type Code	Type
GS0051	Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients

Type Code

Type

GS0051

Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders, autoimmune disorders and other disorders of the immune system, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients

Trademark Filing History

Description	Date	Event Coding
ASSIGNED TO EXAMINER	2002-10-30	1 DOCK D:Assigned to Examiner
NON-FINAL ACTION MAILED	2002-11-13	2 CNRT F:First Action
CASE FILE IN TICRS	2003-05-14	3 CFIT O:Outgoing Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2003-05-05	4 CRFA I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2003-06-03	5 CNSA P:
NOTICE OF PUBLICATION	2003-07-16	6 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2003-08-05	7 PUBO A:Allowance for Publication
NOA MAILED - SOU REQUIRED FROM APPLICANT	2003-10-28	8 NOAM O:Outgoing Correspondence
ABANDONMENT - NO USE STATEMENT FILED	2004-06-30	9 ABN6 S:

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.